New 2026 CAR T cells for autoimmune diseases: 2026 update of the EBMT-ISCT-JACIE practice harmonisation and consensus recommendations Group Autoimmune Diseases Working Party (ADWP) JACIE Working Party Other society 1st listed author Raffaella Greco Journal Lancet Rheumatol.
New 2026 Gaps in guidelines implementation and need for harmonization in toxoplasmosis management after allogeneic stem cell transplantation across EBMT centers: an Infectious Diseases Working Party survey Group Infectious Diseases Working Party (IDWP) 1st listed author Fabio Andreozzi Journal Bone Marrow Transplant.
New 2026 CAR T-cell activity for autoimmune diseases across EBMT centers: an international survey on behalf of the Autoimmune Diseases Working Party and the Cellular Therapy and Immunobiology Working Party Group Autoimmune Diseases Working Party (ADWP) 1st listed author Giorgio Orofino Journal Haematologica.
New 2026 GvHD prophylaxis in elderly patients: post-transplant cyclophosphamide or ATG? A study by the EBMT transplant complications working party Group Complications Working Party (CWP) 1st listed author Lars Klingen Gjærde Journal Bone Marrow Transplant.
New 2026 BEAM versus EAM, FEAM, BeEAM, and TEAM: exploring conditioning strategies in autologous stem cell transplantation for Hodgkin lymphoma a retrospective study of the LWP of EBMT Group Lymphoma Working Party (LWP) 1st listed author Annalisa Paviglianiti Journal Bone Marrow Transplant.
2026 Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome in young adults: A retrospective study on behalf of the EBMT Chronic Malignancies Working Party Group Chronic Malignancies Working Party (CMWP) 1st listed author Antonio Martin Jimenez Jimenez Journal Bone Marrow Transplant.
2026 Correction: Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties Group Autoimmune Diseases Working Party (ADWP) Complications Working Party (CWP) 1st listed author Arsene Mekinian Journal Bone Marrow Transplant.
2026 Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party Group Acute Leukemia Working Party (ALWP) 1st listed author Jesús Duque-Afonso Journal Bone Marrow Transplant.
2026 Allogeneic stem cell transplantation with post-transplantation cyclophosphamide in patients with acute myeloid leukemia achieving first complete remission after one versus two inductions: a study from the ALWP/EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
2026 Pre-CAR-T B-cell-directed immunotherapy exposure and outcomes after CD19 CAR-T for large B-cell lymphoma: An EBMT registry analysis Group GoCART Coalition 1st listed author Jan Christian Schroeder Journal Bone Marrow Transplant.
2026 Correction: Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
2026 Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working party Group Lymphoma Working Party (LWP) 1st listed author Evgenii Shumilov Journal J Hematol Oncol.